Lung cancer patient becomes first in UK to receive a new vaccine
Janusz Racz had six syringes of the jab, each containing genetic material for a different part of the tumour, to train 5 billion cells in his immune system to go on the attack. The vaccine, is made by BioNTech using the same mRNA technology that underpinned its COVID jab.
Friday 23 August 2024 00:34, UK
